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Introduction
Hearing loss also known as silent disability affects over 
275 million people worldwide most of which live in low- 
and moderate-income countries. The number of people 
with debilitating from mild to severe hearing impairment 
has been estimated to be more than 360 million [1]. Social 
problems due to hearing impairment include heavy socio-
economic costs imposed on families, delayed acquisition 
of cognitive and verbal skills, and education achievement-
related problems in children, as well as difficulties with 
finding or keeping job in adults. Meanwhile, costs of edu-
cation of children with special needs can cause a great 
national economic burden. The main causes of hearing loss 
include infectious diseases, such as meningitis, measles, 
mumps, and chronic ear infections, exposure to noise, dam-
age to ear and head, aging, and taking certain drugs with 
toxic effects. Hearing loss and hearing impairment can be 
prevented or, through the early diagnosis and appropriate 
management, treated (by surgery, use of certain instru-
ments, such as hearing aid, and cochlear implant) in half of 
the cases [2].
The genome of eukaryotes consists of both coding and 
non-coding DNA. Coding DNA consists of all open read-
ing frames (ORFs) and exons that are transcribed to RNA 
sequences and even translated to protein sequences. How-
ever, the function of non-coding regions, including introns 
has not fully understood, although some regulatory roles 
have been observed for introns [3].
Another important factors are miRNAs which were dis-
covered and found to be involved in regulating expression 
Abstract miRNAs are important factors for post-tran-
scriptional process that controls gene expression at mRNA 
level. Various biological processes, including growth and 
differentiation, are regulated by miRNAs. miRNAs have 
been demonstrated to play an essential role in development 
and progression of hearing loss. Nowadays, miRNAs are 
known as critical factors involved in different physiologi-
cal, biological, and pathological processes, such as gene 
expression, progressive sensorineural hearing loss, age-
related hearing loss, noise-induced hearing loss, cholestea-
toma, schwannomas, and inner ear inflammation. The miR-
183 family (miR-183, miR-96 and miR-182) is expressed 
abundantly in some types of sensory cells in inner ear spe-
cially mechanosensory hair cells that exhibit a great expres-
sion level of this family. The plasma levels of miR-24-3p, 
miR-16-5p, miR-185-5p, and miR-451a were upregulated 
during noise exposures, and increased levels of miR-21 
have been found in vestibular schwannomas and human 
cholesteatoma. In addition, upregulation of pro-apoptotic 
miRNAs and downregulation of miRNAs which promote 
differentiation and proliferation in age-related degeneration 
of the organ of Corti may potentially serve as a helpful bio-
marker for the early detection of age-related hearing loss. 
This knowledge represents miRNAs as promising diagnos-
tic and therapeutic tools in the near future.
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and function of protein-coding RNAs by Lee and co-work-
ers in 1993 [4]. These small non-coding RNAs [4] are usu-
ally 22- to 42-nucleotide long and are highly conserved in 
plants and animals. These regulatory elements are evolu-
tionarily ancient component for the process of gene regula-
tion [5]. These molecules regulate the expression of over 
30% of genes in different biological processes, such as pro-
liferation, differentiation, survival, migration, apoptosis, 
and death [6].
Cellular reprogramming occurs during the develop-
ment of eukaryotic organisms via both extracellular [7] and 
intracellular agents. Among intracellular factors, histone 
modifications, DNA methylation, and gene expression reg-
ulation via microRNAs have been described. microRNAs 
are found in animals, plants, and some viruses, and they 
function in silencing and post-transcriptional regulation of 
gene expression [8]. Most of miRNAs are located within 
the cell, but some miRNAs are found in extracellular envi-
ronment, such as serum, biological fluids, and the media of 
cell culture [9]. microRNAs can silence the gene expres-
sion via cleavage of the mRNA strand, shortening of the 
poly(A) tail, and affecting the mRNA translation into pro-
teins by ribosomes; phenomena that can be predicted using 
computational biology [10].
To date, over 2500 human miRNAs have been identified 
[11]. Many pathological processes, such as cardiovascular 
and neurological diseases, diabetes, and cancers are associ-
ated with abnormal expression of miRNAs [12, 13]. Inter-
estingly a number of studies have pointed out the impor-
tance of miRNAs in hearing-related diseases. For instance, 
there are evidences that miRNAs can be used as biomarker 
to diagnose noise-induced and age-related hearing loss [20, 
21]. In this work, we have reviewed the role of microRNAs 
in ear-related diseases and hearing loss. We have studied 
the current evidences on the role of miRNAs in inner ear 
evolution and recent research accomplishments and devel-
opments on the role of miRNAs in inner ear biology and 
pathogenesis.
Biogenesis of MicroRNAs
Biogenesis of miRNAs occurs in nucleus and cytoplasm. 
In nucleus, first, RNA polymerase II transcribes pri-
miRNAs from either coding or non-coding areas in the 
genome. pri-miRNAs have a loop-stem structure with 
poly(A) tail at 3′-end and CAP at 5′-end. pri-miRNAs are 
converted to pre-miRNAs by an RNAse III-containing 
complex which is specialized to digest a double-stranded 
RNA (Drosha), and a double-stranded RNA-binding pro-
tein, DGCR8. pre-miRNAs are then transported to cyto-
plasm by exportin-5. In cytoplasm, final processing is 
conducted on pre-miRNA by TRBP/Dicer complex. Dicer 
function leads to formation of a 31 to 42-nucleotide, 
double-stranded RNA with a guide strand and a pas-
senger strand. Passenger strand is destroyed and guide 
strand forms miRNA via binding to RNA-induced silenc-
ing complex (mi-RISC) containing members of Argo-
naute protein family. This complex is complementary to 
3′-UTR of target mRNA. If miRNA sequence is com-
pletely complementary to target mRNA, target mRNA is 
destroyed after binding. However, translation is inhibited, 
in case the miRNA binding to mRNA is incomplete. Each 
miRNA can target several mRNAs [14–18] (Fig. 1).
MicroRNAs in hearing loss
Little is known about molecular basis of progressive 
hearing loss. Recently, the potential role of miRNA as a 
therapeutic agent in regeneration has been demonstrated 
in research on regulatory factors involved in ear diseases 
[19, 20]. miRNAs play a very important role in gene 
expression, physiological and pathological processes, and 
progressive sensorineural hearing loss (SNHL) which 
is mainly due to cochlear hair cells defect or loss. Role 
of miRNAs in pathogenesis of different ear diseases has 
been studied via detecting genetic and somatic mutations 
in miRNAs and their binding sites in target genes [21, 
22]. Recently, mutations in miR-96 have been demon-
strated to be associated with progressive hearing loss in 
humans and mice. Similar to histone modifications and 
DNA methylation, miRNAs have been found to play roles 
in survival and development of organs and cells, such as 
mechanosensory hair cells [23]. Moreover, miRNAs have 
been suggested to be essential and new regulatory fac-
tors for the formation of induced pluripotent stem cells 
(iPSCs) and differentiation of these cells into hair cell 
[24, 25]
MicroRNAs are involved in formation of the inner ear
miRNAs are considered as important factors that widely 
affect the development of inner ear. Microarray analysis, 
quantitative real-time PCR, and in situ hybridization have 
demonstrated that miRNA-182, miRNA-140, miRNA-
200c expressions have distinct temporal and spatial pat-
terns at E13.5 (mouse embryonic day 13.5 of develop-
ment) and E16.5 [26]. mir-96, mir-182, and mir-183 are 
the well-investigated miRNAs that were first detected in 
the otic vesicle, cochlea-vestibule ganglion, and cochlear 
hair cells at E9.5, E11.5, and E17.5, respectively. Accord-
ing to some studies, the expression continued to at least 
P30 (Postnatal Day 30). The expression of other miRNAs 
detected by in situ hybridization is shown in Fig. 2 [27].
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Fig. 1  Biogenesis of miRNA: miRNA biogenesis is a multistep pro-
cess. First, miRNA genes are transcribed by RNA polymerase II in 
the nucleus (step 1). The resulting primary transcript is cleaved by 
Drosha and DGCR8 to produce pre-miRNA (step 2). After expor-
tin-5- and RanGTP-mediated transport to the cytoplasm (step 3), 
the pre-miRNA undergoes its final processing step, which consists 
of Dicer-dependent cleavage just below the stem loop to produce a 
duplex molecule (step 4). The duplex is then separated and usually 
one strand is selected as the mature miRNA and directed to target-
specific mRNAs (step 5)
Fig. 2  Timeline for miRNA expression during development and early postnatal stages of the inner ear for a subset of miRNAs (27). Those 
marked with numbers were only examined at the stage indicated
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The miRNA-183 family in hair cell development 
and deafness
miRNA-183 family (96, 182, and 183) is expressed abun-
dantly in specific sensory cell types in the inner ear. They 
play either distinct or common roles in inner ear cell-
fate determination [28]. In vertebrate hair cells, such as 
zebrafish, the miR-183 family is highly expressed and 
induces extra and ectopic hair cells. Contrariwise, knock-
down causes reduction in numbers of hair cells in the inner 
ear, smaller spiral ganglion neuron (SGNs), and defects in 
semicircular canals [29].
Among the members of this family, miR-96 is expressed 
as a sensory organ-specific miRNA in the mammalian 
cochlea during development. Indeed, in humans and mice, 
some types of non-syndromic progressive hearing loss are 
due to miR-96 mutations [30]. One example is the results 
of the study conducted by Mencia and co-workers who 
found that point mutations in the seed region of miR-96 
result in progressive hearing loss with autosomal dominant 
inheritance pattern [31]. Further investigations on the role 
of a SNP (Single-nucleotide polymorphism) in the seed 
region of hsa-miR-96 revealed two key biological processes 
involved in progressive hearing loss. This SNP leads to a 
significant enrichment of two sets of allele-specific tar-
get genes of hsa-miR-96, including neurotrophin in TRK 
receptor signaling pathway and epidermal growth factor 
receptor signaling pathway [21]. miRNA profiling, target 
analysis, and validation suggest that miRNAs (e.g. miR-
183/Taok1 target pair) are involved in regulating the degen-
erative process of the cochlea after acoustic overstimulation 
[32]. In inner ear hair cells, chloride intracellular channel 
5 (CLIC5) expression is regulated by miR-183 family. In 
other words, CLIC5 3′-UTR contains a highly conserved 
sequence which is a single predicted miR-96/-182-binding 
site. This binding site which is located between nucleotides 
760–766 is the target where miR-96/-182 can regulated the 
CLIC5 [33].
MicroRNAs are involved in age-related hearing loss
The main cause of age-related hearing loss (ARHL) is 
degeneration of the organ of Corti (OC) caused by altera-
tion of miR-29 and miR-34 families that regulate pro-apop-
totic pathways. The expression levels of miR-34a exhibit 
a significant stimulator to increase the cochlea, auditory 
cortex, and plasma in mice during aging. These increases 
are accompanied by elevated hearing thresholds and greater 
hair cells loss. Levels of silent information regulator-1 
(SIRT1), B-cell lymphoma-2, and E2F transcription fac-
tor 3 as targets of miR-34a may potentially serve as useful 
biomarkers to detect ARHL early [34]. Moreover, several 
studies have shown that acetylation of p53 and apoptosis 
is increased via miR-34a/Sirtuin1 (SIRT1)/p53 signaling 
pathway in cochlear hair cells during aging. The findings, 
therefore, suggest a link between age-related apoptosis of 
cochlear hair cell and miR-34a/SIRT1/p53 signaling, which 
may provide a potential target for ARHL [35]. Unlike 
upregulation of this pro-apoptotic miRNA, many miRNA 
families are important for proliferation and differentiation. 
Two examples are miR-181 and miR-183 whose downreg-
ulation has been reported to be associated with cell death 
resulting in ARHL [36].
MicroRNA expression profiles in noise-induced hearing 
loss
There are evidences that noise stimulation or occurrence of 
noise-induced hearing loss (NIHL) affects miRNA expres-
sion. One of the major causes in pathogenesis of NIHL is 
oxidative stress, because the cochlea is metabolically active 
[27]. Cellular response to noise exposure can be detected as 
plasma miRNAs biomarker that may provide new insights 
in pathogenesis of NIHL. In fact, miRNA target analy-
sis may reveal the pathways involved in NHIL and help to 
develop new drugs through identification of the cellular 
stress response components [37]. After noise exposure in 
animal model with noise-induced deafness, the expres-
sion of members of miRNA-183 family exhibits signifi-
cant increase, which shows that this family members may 
play significant roles in the pathogenesis and development 
of NHIL [38]. Moreover, the plasma levels of miR-16-5p, 
miR-24-3p, miR-185-5p, and miR-451a are also known to 
be upregulated in noise exposures [39].
MicroRNA in inner ear inflammation
Inflammation of the inner ear can cause several forms of 
immune-mediated hearing loss. Therefore, understanding 
the inflammatory pathways and its molecular components 
is very helpful to develop drugs and treatments for these 
types of hearing loss [40, 41]. A number of studies have 
discussed the mechanisms of neuroprotective agents against 
cytotoxicity [42, 43]. In addition to identification of genetic 
factors involved in inflammatory hearing loss, miRNAs 
may contribute to gene expression regulation and affect 
the outcome of inflammation in ear. The biological effects 
of miRNAs have been found by ionizing radiation (IR)-
induced cell death in auditory cells using miRNA mim-
ics or inhibitors. Studies conducted by Tan and co-work-
ers on house ear institute OC 1 (HEI-OC1) cells revealed 
that miR-207 is upregulated following IR resulting in IR-
induced apoptosis and enhanced DNA damage. Therefore, 
inhibition or downregulation of miR-207 could be a poten-
tial strategy for protecting cochlear hair cells against IR 
[44]. Another miRNA involved in inner ear inflammation is 
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miR-224 which is a transcriptional target of the key media-
tor of innate immunity, nuclear factor kappa B pathway. 
It is well documented that miR-224 diminishes the innate 
immune response through downregulating Ptx3 expression 
that stimulates the innate immune response [40].
MicroRNAs and epigenetics in inner ear
DNA methylation and histone modifications are epigenetic 
mechanisms that are implicated in human deafness, sug-
gesting that different levels of non-coding genes (such as 
miRNAs) are required for normal hearing [23]. Sensory 
hair cells and supporting cells in the auditory organ of the 
mammalian inner ear arise from a common sensory progen-
itor. Cell fate in developing of organ of Corti is controlled 
by miR-124 which is an epigenetic protective agent for two 
inhibitors of the Wnt pathway, Sfrp4 (secreted frizzled-
related protein4), and Sfrp5. These proteins play essential 
roles in fine-tuning of the expression of genes critical for 
cell patterning (e.g., Hes1 and Hes5) during cochlear dif-
ferentiation [23].
microRNA expression in cholesteatoma 
and schwannoma
The role of miR-21 has been described in some of ear-
related diseases, such as human cholesteatoma growth and 
proliferation, and vestibular schwannomas [45, 46]. Upreg-
ulation of miR-21 is implicated in potential harmful growth 
in the middle ear or in the mastoid bone [45]. Increased 
levels of miR-21 have been also observed in vestibular 
schwannomas [46].
Other miRNAs in hearing loss
Experimental analyses of vestibular hair cells have shown 
that expression of PSIP1-P75 which is a transcriptional co-
activator in the inner ear may be regulated by miR-135b. 
Indeed, some differences between the cochlear and ves-
tibular hair cells are determined by miR-135b which acts 
as a cellular effector [22]. Furthermore, since protection 
of SGNs from ongoing degeneration is an essential step 
to prevent progressive hearing loss, miRNA-base strate-
gies can be designed to prevent or reverse SGN damages. 
Downregulation of TMPRSS3 (transmembrane protease, 
serine3) has been reported to be necessary for SGNs devel-
opment through overexpression of miR-204. Therefore, 
alteration of miR-204 may serve as a potential therapeutic 
target in SNHL [47]. Another key regulator in development 
of hearing organs is miR-6716-3p. This miRNA is involved 
in actin reorganization, sensory hair cell bundle develop-
ment, cell adhesion, and inner ear morphogenesis [48]. 
Since miRNAs can regulate important signaling pathways, 
it is not surprising that they are also involved in cytotoxic-
ity. Indeed, recent findings have suggested a role of miR34a 
and miR34c in antibiotic-induced ototoxicity in a dose-
dependent manner in cochlear cells [42].
MicroRNA editing and transfer
In addition to all above-mentioned roles for various miR-
NAs, an important factor affecting the function of miR-
NAs is their proper trafficking and transfer. An example 
is a membrane protein Cx26. This protein that is required 
for cochlear development is responsible for intercellular 
communication, including miRNA intercellular transfer 
between native cochlear supporting cells. Deficiency of 
Cx26 disrupts miRNA intercellular transfer in the cochlea 
and leads to cochlear developmental disorders and congeni-
tal deafness [49]. In addition to proper transit, all miRNAs 
require a fully functional editing system in the cell; there-
fore, any failure in editing may result in vigorous outcome 
in organ development. For instance, a spectrum of non-
syndromic to syndromic hearing loss is associated with 
mutations in phosphoribosyl pyrophosphate synthetase 1 
(PRPS1), due to the failure of unedited pri-miR-376 clus-
ter (miR-376a-3p, b-3p, c-3p) in regulating the activity of 
PRPS1 in the inner ear [50] (Table 1).
Discussion
To develop effective therapeutic strategies to treat hair cell 
damage, a fundamental and significant step is to identify 
regulatory mechanisms involved [32]. Recently, a common 
mechanism has been demonstrated to be involved in evolu-
tion and reprogramming of inner ear cells in a number of 
different species of vertebrate. The regulatory role of miR-
NAs, particularly miRNA-183 family, and certain genes, 
such as GFI1, POU4F3, and ATOH1, has been confirmed 
in differentiation of stem cells into hair cells and protection 
of hair cells [24]. Moreover, since hundreds of transcripts 
may be regulated simultaneously by the same miRNA, 
miRNAs can certainly be considered as potential therapeu-
tic agents to repair or regenerate hair cells at least in animal 
models [41]. Similarly, since a large proportion of human 
transcriptome is regulated by miRNAs, they can be used in 
diagnosis and prognosis as well as development of drugs. 
Despite advances in the use of cochlear implant to treat 
SNHL, the rate of hearing improvement is not fully satisfy-
ing in people undergoing this therapy. The combination of 
molecular-based methods and stem cell therapies can be a 
promising alternative to cochlear implant. Supporting cells 
differentiation into hair cells that does not occur under nor-
mal conditions may theoretically be induced in adult mam-
mals by alteration and modification of miRNAs level in the 
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cells as well as administration of their transit and cellular 
trafficking. Molecule-based therapies using anti-miRNA 
LNA (miravirsen) and mimic miRNA (MRX34) are being 
investigated in clinical trials, but most of miRNA-based 
therapies are being studied in preclinical studies [17]. 
Recently, circulating miRNAs have attracted attention, 
because they are considered to be frequent and stable bio-
markers in serum and plasma. Further studies are required 
to shed light onto the role of miRNA profile alteration dur-
ing the hearing loss process before miRNAs can be used as 
a biomarker to diagnose hearing loss [34, 53–57]. Briefly, 
in the near future, the patient’s serum miRNAs levels might 
be used, as molecular markers, for diagnosis and progno-
sis of hearing loss. Moreover, they are potential therapeutic 
agents for repair or regenerate hair cells, cell reprogram-
ming, and regenerative medicine.
Conclusion
Efforts are being made to offer an appropriate molecu-
lar marker with capability to predict hearing loss or even 
being used as a diagnostic and prognostic agent alongside 
other pathological or clinical approaches. Among them, 
miRNAs have been demonstrated to become dysfunctional 
during hearing loss and play essential roles in the devel-
opment and progression of this disorder. miRNAs have 
the potential to be used in treating hearing loss. Consider-
ing the nature of miRNAs and the fact that most common 
approaches to screen hearing loss at the early stages fail 
to diagnose this disorder, it is a highly promising strategy 
to study and identify circulating miRNAs as molecular 
markers for progression of hearing loss due to any causes, 
such as ARHL, NIHL, inflammation, Schwannomas, and 
cholesteatoma.
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